Thread: Newest oral disease-modifying treatments haven't been as popular as expected
View Single Post
Old 06-18-2020, 03:52 PM
agate's Avatar
agate agate is offline
Senior Member
  
Join Date: Aug 2006
Location: Wild West
Posts: 1,009
15 yr Member
agate agate is offline
Senior Member
agate's Avatar
 
Join Date: Aug 2006
Location: Wild West
Posts: 1,009
15 yr Member
Default Newest oral disease-modifying treatments haven't been as popular as expected
This article from Medscape Today (June 5, 2020) indicates that the new oral disease-modifying treatments for MS haven't been as popular as they were expected to be--and Ocrevus seems to be the favorite DMT--"Newest oral DMTs haven't yet made a big impact in the MS world":

Newest Oral DMTs Haven't Yet Made a Big Impact in the MS World
__________________
Repeal the law of gravity!

MS diagnosed 1980. Type 2 diabetes, osteoarthritis.
Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, since 12/16/20
agate is offline   Reply With QuoteReply With Quote